23 November 2024NewsAmericasBetsy Haanes SVP, Intellectual Property IGM Biosciences, Theresa Raymer Head of Intellectual Property, Associate General Counsel and Senior Director IP Recor Medical, David Dolberg Senior Director of Intellectual Property Sanaria Inc

WATCH: Essential considerations: patenting and clinical trials

There is an intricate intersection between patenting and clinical trials within the dynamic IP landscape in the life sciences industries. Safeguarding your innovation throughout the research process is critical, necessitating a careful balance between the need to file and when to file, explain speakers from IGM Biosciences, IP Recor Medical, and Sanaria Inc.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
28 April 2026   BioNTech’s former rival—now part of its company—is seeking to assert its mRNA portfolio against Moderna in a new suit over modifications to the highly fought-over molecule.
Americas
23 April 2026   The US pharma giant is spending up to $1 billion to build an end-to-end biosimilar platform and is counting on a decade of expiring biologic patents to make it pay off.
Americas
23 April 2026   Plaintiff alleges that a $6 billion rival probed its records system via a long-term customer, using confidential information to develop its product in the behavioural health tech space.